| Literature DB >> 32772558 |
Ryan Toma1, Nathan Duval1, Benjamin Pelle2, Matthew M Parks1, Vishakh Gopu1, Pedro J Torres1, Francine R Camacho1, Nan Shen1, Subha Krishnan1, Andrew Hatch1, Hal Tily1, Ally Perlina1, Guruduth Banavar1, Momchilo Vuyisich1.
Abstract
To prevent and treat chronic diseases, including cancer, a global application of systems biology is needed. We report here a whole blood transcriptome test that needs only 50 μl of capillary (fingerprick) blood. This test is suitable for global applications because the samples are preserved at ambient temperature for up to 4 weeks and the RNA preservative inactivates all pathogens, enabling safe transportation. Both the laboratory and bioinformatic steps are automated and performed in a clinical lab, which minimizes batch effects and creates unbiased datasets. Given its clinical testing performance and accessibility to traditionally underrepresented and diverse populations, this test offers a unique ability to reveal molecular mechanisms of disease and enable longitudinal, population-scale studies.Entities:
Keywords: RNA-seq; clinically validated; population studies; systems biology; transcriptomics; whole blood
Mesh:
Year: 2020 PMID: 32772558 DOI: 10.2144/btn-2020-0088
Source DB: PubMed Journal: Biotechniques ISSN: 0736-6205 Impact factor: 1.993